Inherited abnormalities in the complex pathways of carbohydrate, amino and organic acids and lipids lead to the inborn errors of metabolism. A variety of genetic aberrations lead to single or multiple protein/enzyme defects at the translational, post-translational and organelle targeting levels that lead to the disease biochemistry and clinical manifestations.
Keywords: intermediary metabolism; genetics; lysosome; gene therapy







